The SGH Center of Excellence aims to advance pathology practice by implementing a fully digital histopathology workflow and deploying AI to increase productivity.
The rapid diagnostics from Abbott and SD Biosensor will enable expanded testing in countries that do not have extensive laboratory facilities.
The acquisition of FTD increases the menu of the Siemens Healthineers Versant kinetic polymerase chain reaction molecular system by more than 80 assays and syndromic panels.
Medicare will now provide benefits for serial use of the Signatera MRD test in patients with stage II or III colorectal cancer.
Read More
Fulgent Genetics says covid-19 and Influenza A/B will be run on a single nasal swab at no additional cost to patients.
Read More
This new service provides high-quality proteins from emerging seasonal and pandemic influenza strains for diagnostics and vaccines.
Read More
Biocartis Group and LifeArc have a new agreement aimed at the development of prototype assays in the field of infectious and immune-related diseases.
Read More
FDA granted separate EUAs for two covid-19 tests: the QDx SARS-CoV-2 Assay and Biocan’s Tell Me Fast Novel Coronavirus IgG/IgM Antibody Test.
Read More
Under the contract, Hologic will expand production of custom sample collection and processing consumables for covid-19 tests.
Read More
Production of tubes for viral transport media has ramped up from 50,000 units to more than 8 million per week.
Read More
The $760 million agreement is for 150 million rapid coronavirus tests called BinaxNOW made by Abbott Laboratories.
Read More
Fulgent Houston will focus on covid-19 testing initially, with capacity for 20,000 tests per day and the ability to expand as demand continues to increase.
Read More
Avero Diagnostics is adding covid-19 serology testing to its portfolio with the addition of the Roche Elecsys Anti-SARS-CoV-2 antibody test.
Read More
The guideline includes myChoice CDx guided management in both newly diagnosed and recurrent ovarian cancer.
Read More
The companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients with HER2 mutations.
Read More
ELITechGroup has distributed more than 3.5 million covid-19 tests worldwide and installed more than 500 of its ELITe InGenius PCR system globally.
Read More
The partnership explores models for real-time identification, patient referral, and clinical trial enrollment of patients with solid tumors and NRG1 fusion.
Read More
An exclusive agreement grants Sysmex America North American rights to distribute and service Siemens Healthineers’ Clinitek Novus Automated Urine Analyzer.
Read More